Status:
NOT_YET_RECRUITING
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Pneumocystis
Immunocompromised Patients
Eligibility:
All Genders
18+ years
Brief Summary
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Eligibility Criteria
Inclusion
- adult patients with suspected pneumocystis
- with an indication for bronchial fibroscopy for BAL or induced sputum
- no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition
Exclusion
- Pneumocystis treated for more than 72 hours
- pregnancy/breast-feeding
- adult patients deprived of liberty, protected
Key Trial Info
Start Date :
April 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06890078
Start Date
April 15 2025
End Date
May 1 2027
Last Update
March 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.